Central Texas will see a strong line of storms come through early Thursday morning. Scott Fisher has the latest details ...

NASA's Jet Propulsion Laboratory monitors asteroid 2022 CE2, expected to safely pass Earth on January 16, 2025. The 370-foot-wide asteroid will come within 2,640,000 miles, over 16 times the ...

Although the Bahrain Darts Masters is still growing as a global event on the PDC circuit, there's still a healthy wedge of prize money on offer for the 16 competing players given the tournament ...

An enormous asteroid potentially larger than the Washington Monument is due to zip past our planet today. For comparison, the Washington Monument is about 555 feet tall, the Golden Gate Bridge is ...

NASA is currently monitoring asteroid 2024 PT5, which is passing by Earth this month at a safe distance. Discovered in August 2024, the 33-foot-wide object has followed a path similar to Earth’s, ...

Asteroid impact sulfur release less lethal in dinosaur extinction. ScienceDaily . Retrieved February 2, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250116133822.htm ...

A massive asteroid, 2022 CE2, is set to make a close flyby of Earth on Thursday. The 370-foot asteroid will travel at an astounding speed of 47,721 km/h but poses no threat, passing at a safe ...

It will show a mix of live matches with non-PDC Tour Card holders and expert analysis, as well as taking viewers behind-the-scenes. Top of the agenda is the Super Series Tournaments, which ...

因此，多肽偶联药物（PDC）作为ADC药物后的新一代靶向治疗药物，在2018年Lutathera获批上市以来已有2款PDC药物获批（1款已退市），多条研发管线推进至临床后期，已成为全球偶联药物新的研发热点。 多肽偶联药物（Peptide-Drug Conjugate，PDC）是一种新型的偶联药物 ...

因此，多肽偶联药物（PDC）作为ADC药物后的新一代靶向治疗药物，在2018年Lutathera获批上市以来已有2款PDC药物获批（1款已退市），多条研发管线推进 ...

This flyby is a rare event, occurring once every decade for an asteroid of this size. Experts confirm Alinda is among the five largest asteroids expected to come this close to Earth by 2200. NASA ...

因此，多肽偶联药物（PDC）作为ADC药物后的新一代靶向治疗药物，在2018年Lutathera获批上市以来已有2款PDC药物获批（1款已退市），多条研发管线推进至临床后期，已成为全球偶联药物新的研发热点。 PDC药物的结构和作用机制 多肽偶联药物（Peptide-Drug Conjugate ...